SCHEMBL5598264

SCHEMBL5598264

O=C(NC(O)C1CCCCCC1)c1ccccc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.54
TDP1 Q9NUW8 2/20 0.54
ALDH1A1 P00352 3/20 0.51
POLB P06746 1/20 0.49
ITGB1 P05556 1/20 0.48
ITGA4 P13612 1/20 0.48
ITGB7 P26010 1/20 0.48
P2RX7 Q99572 1/20 0.48
TAS1R3 Q7RTX0 1/20 0.48
TAS1R1 Q7RTX1 1/20 0.48
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
EPHX2 P34913 1/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
NPC1 O15118 1/20 0.46
PYGL P06737 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5643173 0.84 TAS1R3 (0.64) RAB9ATDP1ALDH1A1ITGB1ITGA4
SCHEMBL5598411 0.82 NPC1 (0.64) RAB9ATDP1ALDH1A1HPGDMAPT
SCHEMBL12484097 0.82 P2RX7 (0.44) RAB9ATDP1ALDH1A1P2RX7TAS1R3
SCHEMBL12483302 0.81 MEN1 (0.46) TDP1ITGB1ITGA4ITGB7HPGD
SCHEMBL4481164 0.79 SMN1; SMN2 (0.41) RAB9ATDP1ALDH1A1P2RX7TAS1R3
SCHEMBL5779043 0.79 METAP2 (0.41) RAB9ATAS1R3TAS1R1HPGDSMN1; SMN2
SCHEMBL12482790 0.78 PKM (0.40) RAB9ATAS1R3TAS1R1HPGDTSHR
SCHEMBL5598241 0.78 RAB9A (0.53) RAB9AALDH1A1TSHRLMNAMAPT
SCHEMBL6171268 0.78 RAB9A (0.53) RAB9AALDH1A1TSHRLMNAMAPT
SCHEMBL5598470 0.78 RAB9A (0.53) RAB9AALDH1A1TSHRLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1763353-A1 COMBINATION THERAPIES UTILIZING BENZAMIDE INHIBITORS OF THE P2X<sb>7</sb> RECEPTOR Warner-Lambert Company LLC (US) 2007-03-21 EP disclosed
WO-2006003517-A1 COMBINATION THERAPIES UTILIZING BENZAMIDE INHIBITORS OF THE P2X7 RECEPTOR WARNER-LAMBERT COMPANY LLC (US) 2006-01-12 WO disclosed